More PRNewswire
View Older Stories View Newer Stories-
Flare Therapeutics to Present at Goldman Sachs 45th Annual Global Healthcare Conference
-
Waters Becomes First Liquid Chromatography Column Provider to Receive My Green Lab ACT Ecolabel Certification
-
URW and TOCA Announce Partnership to Expand TOCA Social Soccer Entertainment and Dining Venues Throughout Europe
-
Apotex Completes Acquisition of Searchlight, a leading Canadian-based Specialty Innovative Branded Pharmaceutical Company
-
New Survey From NaturaLawn® of America Reveals Mosquitoes Dominate Homeowners' Yard Worries, With Ticks Close Behind
-
Ontotext Further Enriches Knowledge Graphs - Latest Version of Metadata Studio Provides Text Analytics of Unstructured Documents
-
Bybit Kicks Off P2P Advertiser Recruitment in Argentina, Offering Exclusive Benefits
-
Calamos Launches CPNJ, First ETF to Provide 100% Downside Protection to Nasdaq-100® with a 10.20% Upside Cap Over One Year
-
Psylo Announces First Close on $8 Million Series Seed Financing to Advance Next-Generation Neuroplastogens at BIO Conference in San Diego
-
Caju AI closes a $3 million round from a Leading Venture Firm and Family Office to Meet Growing Demand for Its Customer Engagement Platform
-
Many Family Caregivers Avoid Personal Travel, New AARP Report Shows
-
TECVAYLI® (teclistamab-cqyv) shows sustained deep and durable responses in patients with relapsed or refractory multiple myeloma
-
Next Bridge Hydrocarbons Announces Cordax Settlement
-
24 HOUR FITNESS TO LAUNCH NEW FITNESS FORMATS FOCUSED ON RECOVERY TRAINING AND LONGEVITY
-
Cloudera Makes Bold Bet on Strategic Acquisition of Verta's Operational AI Platform
-
Equality Health Chief Clinical Officer to Present at RISE Value-Based Care Summit
-
Icelandic Glacial™ Launches Two New TV Spots to Support the "You Are What You Drink, Be Exceptional." Campaign
-
Valens Semiconductor Acquires Acroname, Bolstering its Innovative USB Offering for the Industrial Market
-
HistoIndex to Showcase Groundbreaking AI-powered Stain-free Digital Pathology Advances with 8 Accepted Abstracts at EASL Congress 2024
-
Syndigo Study: Incomplete, Inconsistent Product Content Impacts Retailers' Sales
-
Amwins Partners with Kilpatrick Companies
-
Trulieve Announces Opening of 200th Dispensary
-
Over 1,000 Sign-On to Oppose House Plan to Exclude CBOs from PreK for All
-
WildFire Energy Announces Bolt-On Eagle Ford Acquisition
-
Elastin Biosciences Announces Positive Preclinical In Vivo Data Demonstrating Elastin Preservation and Restoration in Models of Abdominal Aortic Aneurysm and Williams Syndrome
-
Thompson Thrift Earns Spot on IBJ Fast 25 List of Fastest-Growing Companies
-
Ledge Launches First-of-its-Kind PartyPad™
-
LANDSEA HOMES CLOSES ON 44 HOMESITES FOR A NEW COMMUNITY IN ANAHEIM, CA
-
Matterworks Launches PyxisTM - First AI-Powered, Turn-Key Platform for Identification and Absolute Quantitation from Mass Spectrometry Data
-
Caixin Summer Summit 2024 Concludes Successfully: Embracing 'New Missions, New Responsibilities'
-
Omdia research predicts DCIM market to reach $6.3bn by 2030, accelerating OT-IT convergence
-
TDS TO SELL ITS ONENECK BUSINESS TO US SIGNAL
-
30TH EDITION OF THE CONFERENCE OF MONTREAL: A MILESTONE IN GLOBAL COLLABORATION
-
Beyond Borders 2024: Innovative biotech industry is well positioned for a comeback when the financing environment improves, says EY report:
-
Paul Thompson is new CEO of KinderCare Learning Companies
-
Kenon Holdings Reports Q1 2024 Results and Additional Updates
-
Welltower Raises 2024 Guidance and Issues Business Update
-
Welltower Board of Directors Approves 10% Increase in Quarterly Dividend to 67c per Share
-
USANA Executive Chairman Kevin Guest Encourages Self-Renewal with June's "Rebuild Your Life Month"
-
Neurocrine Biosciences Announces Publication of Primary CAHtalyst™ Pediatric Phase 3 Study Results of Crinecerfont for the Treatment of CAH in The New England Journal of Medicine
-
Relmada Therapeutics to Participate in the 2024 Jefferies Global Healthcare Conference
-
Neurocrine Biosciences Announces Publication of Primary CAHtalyst™ Adult Phase 3 Study Results of Crinecerfont for the Treatment of CAH in The New England Journal of Medicine
-
AUXLY ANNOUNCES ANNUAL GENERAL MEETING OF SHAREHOLDERS
-
Health Recovery Solutions Appoints Jason Comer as CEO to Lead Next Phase of Growth
-
DeFi Technologies' New Business Line, DeFi Alpha, a Specialized Arbitrage Trading Desk, Generates an Additional C$59.2 Million (US$43.4 Million) from Low-Risk Arbitrage Trades, Totaling Over C$11
-
Spotline to Showcase Innovative Solutions at DIA 2024 in San Diego
-
GD's Dongguan unleashes trend of Chinese art toys culture in San Francisco
-
"Inspiration as Response: Eugen Popa and Contemporary Chinese Painting Documentation Exhibition" Opens at the China Cultural Center in Bucharest, Romania
-
Brennan Acquires Two Distribution Buildings in Denver
-
Illumina appoints Everett Cunningham Chief Commercial Officer
